636 related articles for article (PubMed ID: 28831506)
1. [Cystic pancreatic tumors: diagnostics and new biomarkers].
Berger AW; Seufferlein T; Kleger A
Chirurg; 2017 Nov; 88(11):905-912. PubMed ID: 28831506
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.
Yip-Schneider MT; Wu H; Dumas RP; Hancock BA; Agaram N; Radovich M; Schmidt CM
J Am Coll Surg; 2014 Apr; 218(4):608-17. PubMed ID: 24491241
[TBL] [Abstract][Full Text] [Related]
3. [Intraductal papillary mucinous neoplasm of the pancreas (IPMN)--standards and new aspects].
Distler M; Welsch T; Aust D; Weitz J; Grützmann R
Zentralbl Chir; 2014 Jun; 139(3):308-17. PubMed ID: 24241954
[TBL] [Abstract][Full Text] [Related]
4. [Cystic tumors of the pancreas].
Grützmann R; Saeger HD
Chirurg; 2010 Aug; 81(8):755-68; quiz 769. PubMed ID: 20694789
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic intraepithelial neoplasia in patients with intraductal papillary mucinous neoplasms: the interest of endoscopic ultrasonography.
Maire F; Couvelard A; Palazzo L; Aubert A; Vullierme MP; Rebours V; Hammel P; Sauvanet A; Levy P; Ruszniewski P
Pancreas; 2013 Nov; 42(8):1262-6. PubMed ID: 24152960
[TBL] [Abstract][Full Text] [Related]
6. Cystic neoplasia of the pancreas: pathology and biology.
Adsay NV
J Gastrointest Surg; 2008 Mar; 12(3):401-4. PubMed ID: 17957438
[TBL] [Abstract][Full Text] [Related]
7. Approach to cystic lesions of the pancreas.
Schmid RM; Siveke JT
Wien Med Wochenschr; 2014 Feb; 164(3-4):44-50. PubMed ID: 24254128
[TBL] [Abstract][Full Text] [Related]
8. [Intraductal papillary mucinous neoplasia: which findings support observation?].
Mayerle J; Kraft M; Menges P; Simon P; Ringel J; Partecke LI; Heidecke CD; Lerch MM
Chirurg; 2012 Feb; 83(2):123-9. PubMed ID: 22271054
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA from pancreatic duct aspirate differentiates cystic lesions of the pancreas.
Henry JC; Bassi C; Giovinazzo F; Bloomston M
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S661-6. PubMed ID: 23884752
[TBL] [Abstract][Full Text] [Related]
10. [Strategy in intraductal papillary mucinous neoplasm of the pancreas].
Navarro Colás S; Vaquero Raya EC
Gastroenterol Hepatol; 2012 Nov; 35(9):652-9. PubMed ID: 22832084
[TBL] [Abstract][Full Text] [Related]
11. [Pancreatic cystic space-occupying lesions-Diagnostics, treatment and follow-up care : Current recommendations taking the current German S3 guidelines on pancreatic cancer into account].
Brunner M; Häberle L; Esposito I; Grützmann R
Chirurg; 2022 May; 93(5):461-475. PubMed ID: 35316346
[TBL] [Abstract][Full Text] [Related]
12. Incidental Intraductal Papillary Mucinous Neoplasm, Cystic or Premalignant Lesions of the Pancreas: The Case for Aggressive Management.
El Gammal AT; Izbicki JR
Surg Clin North Am; 2018 Feb; 98(1):141-155. PubMed ID: 29191271
[TBL] [Abstract][Full Text] [Related]
13. Can we predict the progression of premalignant pancreatic cystic tumors to ductal adenocarcinoma?
Chidambaram S; Kawka M; Gall TM; Cunningham D; Jiao LR
Future Oncol; 2022 Jul; 18(23):2605-2612. PubMed ID: 35730473
[TBL] [Abstract][Full Text] [Related]
14. Cyst fluid SPINK1 may help to differentiate benign and potentially malignant cystic pancreatic lesions.
Räty S; Sand J; Laukkarinen J; Vasama K; Bassi C; Salvia R; Nordback I
Pancreatology; 2013; 13(5):530-3. PubMed ID: 24075519
[TBL] [Abstract][Full Text] [Related]
15. Precursor lesions of pancreatic cancer: molecular pathology and clinical implications.
Singh M; Maitra A
Pancreatology; 2007; 7(1):9-19. PubMed ID: 17449961
[TBL] [Abstract][Full Text] [Related]
16. Cystic lesions and intraductal neoplasms of the pancreas.
Fasanella KE; McGrath K
Best Pract Res Clin Gastroenterol; 2009; 23(1):35-48. PubMed ID: 19258185
[TBL] [Abstract][Full Text] [Related]
17. One of the multifocal intraductal papillary mucinous neoplasms with the clinical characteristics of mucinous cystic neoplasm.
Hata T; Sakata N; Motoi F; Unno M
BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23420728
[TBL] [Abstract][Full Text] [Related]
18. [Cystic pancreatic lesions-indications, timing and reasons for surveillance].
Vornhülz M; Sirtl S; Orgler E; Weniger M; Schirra J; Beyer G; Mayerle J
Radiologie (Heidelb); 2023 Dec; 63(12):900-907. PubMed ID: 37878017
[TBL] [Abstract][Full Text] [Related]
19. Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Moris D; Damaskos C; Spartalis E; Papalampros A; Vernadakis S; Dimitroulis D; Griniatsos J; Felekouras E; Nikiteas N
Anticancer Res; 2017 May; 37(5):2185-2194. PubMed ID: 28476781
[TBL] [Abstract][Full Text] [Related]
20. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.
Bae SY; Lee KT; Lee JH; Lee JK; Lee KH; Rhee JC
Dig Liver Dis; 2012 Mar; 44(3):257-60. PubMed ID: 22030480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
